Turkey

Western Asia

Contents

1. Regulatory Overview
2. Regulatory Pathways
3. Available Drugs

Regulatory Overview

Turkey is regulated by the TITCK. The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

TITCK

Regulatory Pathways (1)

TITCK Compassionate Use Authorization – Turkey 21 days

Turkish Medicines and Medical Devices Agency (TITCK) allows compassionate use of unlicensed medicines for patients with serious or life-threatening conditions.

Application Form: TITCK Compassionate Use Application

Legal Basis: Law No. 1262 on Pharmaceuticals

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: TITCK Compassionate Use Guidance

Drugs Available (1)

Drug	Access Route	Status	Lead Time
tacrolimus ophthalmic	—	—	—

Turkey

ISO Code	`TR`
Region	Western Asia
Regulatory Authority	TITCK
Pathways	1 documented
Drugs Available	1 drug(s)